The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study

NCT00599222 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Neovascular Age-related Macular Degeneration

Interventions

BIOLOGICAL: ranibizumab
PROCEDURE: TTT
PROCEDURE: Sham TTT

Sponsor

Anders Kvanta